NAA15 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.277600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.894200E-01
Normal-vs-Stage2
7.015800E-01
Normal-vs-Stage3
5.273400E-01
Normal-vs-Stage4
1.996010E-01
Stage1-vs-Stage2
8.815800E-01
Stage1-vs-Stage3
1.592820E-01
Stage1-vs-Stage4
2.018400E-01
Stage2-vs-Stage3
2.553200E-01
Stage2-vs-Stage4
2.922000E-02
Stage3-vs-Stage4
6.959600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.436400E-01
Normal-vs-AfricanAmerican
4.168000E-01
Normal-vs-Asian
9.110200E-01
Caucasian-vs-AfricanAmerican
1.737790E-01
Caucasian-vs-Asian
4.083600E-01
AfricanAmerican-vs-Asian
1.587830E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.210400E-01
Normal-vs-Female
6.151600E-01
Male-vs-Female
2.910200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.958000E-01
Normal-vs-Age(41-60Yrs)
4.571400E-01
Normal-vs-Age(61-80Yrs)
9.031800E-01
Normal-vs-Age(81-100Yrs)
8.356000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.532600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.982400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.282000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.119600E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.755000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.542800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.662200E-01
Normal-vs-Daily Drinker
8.415000E-01
Normal-vs-Weekly Drinker
8.804800E-01
Normal-vs-Occasional Drinker
4.949800E-01
Normal-vs-Social Drinker
6.244200E-01
Non Drinker-vs-Daily Drinker
6.191200E-01
Non Drinker-vs-Weekly Drinker
8.180600E-01
Non Drinker-vs-Occasional Drinker
1.493800E-01
Non Drinker-vs-Social Drinker
3.481600E-01
Daily Drinker-vs-Weekly Drinker
5.285200E-01
Daily Drinker-vs-Occasional Drinker
7.223900E-02
Daily Drinker-vs-Social Drinker
1.830790E-01
Weekly Drinker-vs-Occasional Drinker
3.434800E-01
Weekly Drinker-vs-Social Drinker
5.720800E-01
Occasional Drinker-vs-Social Drinker
6.953800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.915800E-01
Normal-vs-Grade 2
1.160990E-01
Normal-vs-Grade 3
1.140150E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.097170E-01
Grade 1-vs-Grade 3
4.293600E-02
Grade 1-vs-Grade 4
3.915800E-01
Grade 2-vs-Grade 3
2.709000E-01
Grade 2-vs-Grade 4
1.160990E-01
Grade 3-vs-Grade 4
1.140150E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.183200E-01
Normal-vs-NonDiabetic
7.884000E-01
Diabetic-vs-NonDiabetic
6.453400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.766000E-01
Normal-vs-NoPancreatitis
7.908400E-01
Pancreatitis-vs-NoPancreatitis
8.282200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.349400E-01
Normal-vs-N1
6.946600E-01
N0-vs-N1
8.712400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.810400E-01
Normal-vs-TP53-NonMutant
7.632000E-01
TP53-Mutant-vs-TP53-NonMutant
4.334300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
